The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

J.P. Morgan, Morgan Stanley and Piper Sandler acted as joint book-running managers for the offering. Stifel and Canaccord Genuity acted as co-managers for the offering.

By Rishab Shaju and Ateev Bhandari (Reuters) -Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares ...

Heartflow announced today that it closed its upsized initial public offering (IPO) with proceeds totaling approximately $364.2 million.

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

Shares of Heartflow are slated to make their trading debut Friday after the coronary-care company's upsized initial public offering was priced above increased expectations.

Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...